CTXR compared with NNVC: revenue, margins and what each company keeps, and the suppliers and customers both name

CTXRCitius Pharmaceuticals, Inc.

Mkt capRevenueRevenue

NNVCNanoviricides, Inc.

Mkt capRevenueRevenue

Compare

CTXRCitius Pharmaceuticals, Inc.

NNVCNanoviricides, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

CTXR2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Oct 27 '26—▲+11.62%—

Q3 FY26±41.1%▼−25.62%×0.62

NNVC

No earnings history for NNVC.

= impliedCTXR realized, solidNNVC realized, hatchedOne scale, both sides: full bar = 42%× = |realized| ÷ impliedSource: market data

CTXRCitius Pharmaceuticals, Inc.

0.53▼−3.09%· post 0.57· delayed

Mkt cap$15.1MRevenue$1MQ3 FY26

NNVCNanoviricides, Inc.

1.41▲+1.99%· post 1.28· delayed

After hoursNov 5 '26delayed

Mkt cap$35.2MRevenue—

Compare

After hoursNov 5 '26delayed

CTXRCitius Pharmaceuticals, Inc.

NNVCNanoviricides, Inc.

0.53▼−3.09%post 0.57delayed

Price

1.41▲+1.99%post 1.28delayed

$15.1M

Mkt cap

$35.2M

Q3 FY26$1M

Revenue

—

CTXR0.53▼−3.09%vsNNVC1.41▲+1.99%After hoursNov 5 '26delayed